NYSE:MDTMedical Equipment
Medtronic Antitrust Verdict And What It Could Mean For Valuation
A U.S. District Court jury found Medtronic (NYSE:MDT) liable in a major antitrust case related to advanced bipolar electrosurgical devices.
The jury concluded that Medtronic engaged in monopolistic conduct in the bipolar electrosurgical devices market.
Medtronic was ordered to pay substantial damages to Applied Medical and faces ongoing requests for injunctive relief on its contract practices.
Medtronic, a large medical technology company, sells a broad range of devices used in surgical,...